Founded Date: 1887-01-01
Technology: Biotechnology, Health Care, Medical, Pharmaceutical
Investor Type: Technology - oriented Investor with Venture Investment Focus
Funding Status: Post-IPO Debt
Total Funding: 6080000000
Employee Number: 10001+
Headquarters: New York, New York, United States
Last Funding Date: 2022-02-15
Investors Number: 13
Last Funding Type: Post-IPO Debt
Estimated Revenue: $1B to $10B
Investment Stage: Early Stage Venture, Venture
Acquisitions Number: Made Acquisitions
Number Of Exists: 11
Industry: Longevity Biomarkers